Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Summary

An expanded access program that provides INOpulse treatment to patients with serious disease or conditions associated with pulmonary hypertension associated with pulmonary fibrosis who are not able to participate in the Sponsor's ongoing Phase 3 REBUILD clinical.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications